+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain



In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain



Neurochemical Research 33(11): 2250-2256



Amine transporters are major target for development of various pharmacological agents to treat behavioral disorders. Serotonin transporters (SERT) have been implicated in the etiology of depression and drugs acting on SERT can be effective in treating depression. The aim of the present study was to study the in vivo effect of various antidepressants on [(3)H]paroxetine binding to SERT in regions of rat brain. Rats were treated with tricyclic antidepressant (TCAs) such as amitriptyline (AMI), serotonin/norepinephrine reuptake inhibitor (SNRIs) such as clomipramine (CMI), and selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (FLX) and citalopram (CIT) (10 mg/kg body wt.) for 30 days. Density of SERT was measured in cortex and hippocampus using [(3)H]paroxetine (0.03-1.0 nM) in presence and absence of 10 muM fluoxetine as displacer. It was observed that the density of cortical SERT was significantly decreased with CMI (68%, P < 0.0001), FLX (67%, P < 0.0001), CIT (54%, P < 0.0001), and AMI (52%, P < 0.0001) treatment, when compared to the density of 120.7 +/- 4.0 fmol/mg protein in control rats, without altering the affinity (Kd) of [(3)H]paroxetine to the transporters. The density of SERT in hippocampus was also significantly decreased with FLX (65%, P < 0.0001), CMI (54%, P < 0.0001), CIT (52%, P < 0.0001) and AMI (46%, P < 0.0001) treatment, when compared to the density of 74.0 +/- 2.6 fmol/mg protein in control rats, without altering the affinity of [(3)H]paroxetine to the transporters. Displacement study showed high affinity for CMI > CIT > FLX. The results suggest that chronic antidepressant treatment significantly down-regulates both cortical and hippocampal SERT in rat brain and SSRIs have high affinity for SERT than TCAs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053779548

Download citation: RISBibTeXText

PMID: 18437564

DOI: 10.1007/s11064-008-9703-z


Related references

Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain. Synapse 61(9): 724-731, 2007

A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake. Bioorganic and Medicinal Chemistry 20(21): 6344-6355, 2012

Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain. Synapse 38(4): 403-412, 2000

Selective in vitro and in vivo binding of (125I)ADAM to serotonin transporters in rat brain. Synapse (New York) 38(4): 403-412, 2000

Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo. European Journal of Pharmacology 52(1): 11-16, 1978

Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket. Journal of Biological Chemistry 287(52): 43694-43707, 2012

Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652. Psychopharmacology 164(4): 341-348, 2002

Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain. Synapse 34(1): 77-80, 1999

In vivo kinetics of serotonin clearance is dependent on brain region and density of serotonin and norepinephrine transporters. Society for Neuroscience Abstracts 26(1-2): Abstract No -624 16, 2000

Inhibitory and regulatory binding sites on the rat brain serotonin transporter: molecular weight of the [3H]paroxetine and [3H]citalopram binding proteins. European Journal of Pharmacology 189(2-3): 129-134, 1990

Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro. Japanese Journal of Pharmacology 71(4): 291-298, 1996

3H]paroxetine binding and serotonin content of rat brain: absence of changes following antidepressant treatments. European Journal of Pharmacology 235(1): 137-142, 1993

Correlation between tritiated paroxetine binding and regional serotonin concentration in rat and rabbit brain. Society for Neuroscience Abstracts 16(1): 72, 1990

Evaluation of [3H]paroxetine as an in vivo ligand for serotonin uptake sites: a quantitative autoradiographic study in the rat brain. Synapse 13(1): 1-9, 1993

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue. Brain Research 486(2): 261-268, 1989